SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
29-Jan-13 8:07 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 25-Jan-15 | Payment of Exercise | 1,034 | $24.75 | $25,591.50 | (< 1%) 131.91K to 130.88K | |
04-Mar-13 8:17 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 01-Mar-13 | Disposition (change in control) | 222,676 | $25.00 | $5,566,900.00 | (100%) 222.68K to 0 | |
29-Jan-13 8:07 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 26-Jan-13 | Payment of Exercise | 846 | $24.75 | $20,938.50 | (< 1%) 133.13K to 132.28K | |
29-Jan-13 8:07 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 26-Jan-13 | Option Exercise | 2,250 | -- | -- | 2% 130.88K to 133.13K | |
29-Jan-13 8:07 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 25-Jan-13 | Option Exercise | 2,750 | -- | -- | 2% 129.16K to 131.91K | |
25-Jan-13 8:44 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 23-Jan-13 | Option Exercise | 39,620 | $6.39 | $253,160.00 | 27% 149.16K to 188.78K | |
25-Jan-13 8:44 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 23-Jan-13 | Planned Private Option Sale | 39,620 | $24.76 | $980,991.00 | (21%) 188.78K to 149.16K | |
25-Jan-13 8:44 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 23-Jan-13 | Private Sale (Planned) | 20,000 | $24.76 | $495,200.00 | (13%) 149.16K to 129.16K | |
14-Feb-12 5:42 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 14-Feb-12 | Private Sale (Planned) | 30,999 | $15.62 | $484,142.00 | (17%) 180.16K to 149.16K | |
14-Feb-12 5:42 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 13-Feb-12 | Private Sale (Planned) | 2,800 | $16.00 | $44,800.00 | (2%) 182.96K to 180.16K | |
10-Feb-12 4:34 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 08-Feb-12 | Private Sale (Planned) | 26,201 | $16.00 | $419,216.00 | (13%) 209.16K to 182.96K | |
07-Feb-12 7:33 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 06-Feb-12 | Private Sale (Planned) | 19,868 | $15.00 | $298,020.00 | (9%) 229.03K to 209.16K | |
07-Feb-12 7:33 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 03-Feb-12 | Private Sale (Planned) | 132 | $15.00 | $1,980.00 | (< 1%) 229.16K to 229.03K | |
27-Jan-12 8:23 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 26-Jan-12 | Payment of Exercise | 943 | $13.84 | $13,051.10 | (< 1%) 230.1K to 229.16K | |
27-Jan-12 8:23 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 26-Jan-12 | Option Exercise | 2,250 | -- | -- | < 1% 227.85K to 230.1K | |
21-Dec-11 4:11 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 19-Dec-11 | Private Sale (Planned) | 20,000 | $14.00 | $280,000.00 | (8%) 247.85K to 227.85K | |
21-Mar-11 6:57 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 17-Mar-11 | Option Exercise | 35,846 | $0.74 | $26,647.90 | 17% 212.01K to 247.85K | |
08-Mar-11 5:48 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 04-Mar-11 | Private Sale | 30,000 | $16.10 | $482,979.00 | (12%) 242.01K to 212.01K | |
16-Dec-09 7:36 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 14-Dec-09 | Option Exercise | 10,000 | $3.36 | $33,630.00 | 3% 332.4K to 342.4K | 17% |
16-Dec-09 7:36 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 14-Dec-09 | Private Option Sale | 10,000 | $9.54 | $95,370.00 | (3%) 342.4K to 332.4K | |
28-May-09 4:21 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 27-May-09 | Option Exercise | 60,000 | $0.74 | $44,604.00 | 18% 332.4K to 392.4K | |
28-May-09 4:21 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 27-May-09 | Planned Private Option Sale | 20,000 | $10.01 | $200,200.00 | (5%) 392.4K to 372.4K | |
28-May-09 4:21 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 27-May-09 | Private Sale (Planned) | 40,000 | $10.01 | $400,400.00 | (11%) 372.4K to 332.4K | |
28-May-09 4:21 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 26-May-09 | Planned Private Option Sale | 40,000 | $9.00 | $360,000.00 | (11%) 372.4K to 332.4K | |
22-Jan-10 2:51 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 20-May-09 | Acquisition (other) | 1,423 | $2.63 | $3,749.60 | < 1% 330.98K to 332.4K | 50% |